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ABSTRACT
End stage renal disease (ESRD) is one of the major health care burdens worldwide. Emergency staff are 
well aware of the frequent use of their services by dialysis patients. In this article we discuss the urgent and 
serious medical problems that bring the dialysis patient to the emergency department (ED), and the special 
considerations in the management of such patients in the acute care setting. The main medical problems in 
dialysis patients presenting to the emergency department are as follows: emergent acid-base and electrolyte 
disorders; fever; cardiovascular emergencies; dyspnea; angina/chest pain; anemia and emergencies related 
to access. In conclusion, hemodialysis (HD) and peritoneal dialysis (PD) patients frequently utilize ED services 
because of their proneness to a variety of emergency medical problems.
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INTRODUCTION
Kidney disease is classified based on the glomerular 
filtration rate (GFR). The National Kidney Foundation 
Kidney Disease Outcome Quality Initiative (KDOQI) 
Advisory Board published Clinical Practice Guidelines 
for Chronic Kidney Disease in 2002. These guide-
lines provided a definition for chronic kidney disease 
(CKD) and established a classification system based 
on the GFR. CKD is defined as either kidney dam-
age or GFR < 60 mL/min/1.73 m2 for 3 months or 
longer  [1]. Diabetes and hypertension are the two 
most common causes of CKD [2]. This article discuss-
es the end stage renal disease (ESRD), as defined by 
a GFR of less than 15 mL/min/1.73 m2 or treatment 
with dialysis. ESRD is one of the major health care 
burdens worldwide. Renal replacement therapy (RRT) 
consists of two basic modalities: kidney transplant 
(KTx) and dialysis. KTx is now recognized as the treat-
ment of choice for patients with ESRD who would 
otherwise require dialysis. KTx is associated with pos-
sibly longer survival and quality of life [3]. According 
to the 2016 Annual Data Report of the United States 
Renal Data System, about 678,383 prevalent cases 
of ESRD are being treated by dialysis, with approxi-
mately 63% receiving hemodialysis (HD), about 7% 
on continuous ambulatory peritoneal dialysis (CAPD) 
while 30% had a functioning KTx [2].
HD is usually performed 3 times per week for 
4–5 hours, blood is drawn out of and returned 
to the circulation through a arteriovenous fistula 
(AVF) or central venous catheters. The patient is 
scheduled for a specific appointment time and is 
usually dialyzed on a Monday-Wednesday-Friday 
or Tuesday-Thursday-Saturday schedule. The Kid-
ney Disease Outcomes Quality Initiative guidelines 
recommend that the prevalence of central venous 
catheters should be below 10% in HD. Hemodialysis 
corrects the fluid overload and removes unwanted 
waste products. In CAPD, the peritoneum is used 
as the semipermeable membrane separating the 
peritoneal capillary blood from dialysate instilled 
into the peritoneal cavity through an implanted 
catheter (Tenckhoff catheter). CAPD is performed 
manually (generally 4 times a day) or, in automated 
peritoneal dialysis (APD), by a cycler machine during 
the night.
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Emergency staff are well aware of the frequent use 
of their services by dialysis patients. In this article we 
discuss the urgent and serious medical problems that 
bring the dialysis patient to the emergency depart-
ment (ED), and the special considerations in the man-
agement of such patients in the acute care setting.
COMMON MEDICAL PROBLEMS IN DIALYSIS 
PATIENTS PRESENTING TO THE EMERGENCY 
DEPARTMENT
Emergent acid-base and electrolyte disorders in 
dialysis patients
Firstly, the nurse should make sure the sample is not 
hemolyzed. Hemolysis is a common cause of falsely 
diagnosing hyperkalemia. The hyperkalemic dialy-
sis patient is usually asymptomatic. Common fac-
tors for hyperkalemia in HD patients are as follows: 
noncompliance with dietary potassium restriction; 
angiotensin-converting enzyme inhibitors; missed 
dialysis session; and severe metabolic acidosis. Gen-
erally, only when the serum potassium level exceeds 
7.0 mEq/L, may generalized muscle weakness occur. 
Changes in ECG (peaked T waves, prolonged PR 
interval, disappearance of P waves and finally a sine 
wave [4]) are the best guide to the management of 
the hyperkalemia. In dialysis patients, like in gen-
eral population, the serum potassium level can be 
treated effectively by the use of IV insulin and glu-
cose. The onset of effects is about 20–30 minutes, 
and lasts for about 5 hours. The other immediate 
method is an IV infusion of 10 mL of 10% Calcium 
chloride solution (effects least 30–60 min). Another 
method is the use of oral or rectal sodium polysty-
rene sulfonate (effects is at least 12 hours, and lasts 
for at least 24 hours [5]. Patients should as soon as 
possible receive adequate dialysis e.g. continuous 
venovenous hemodiafiltration (CVVHDF) (Fig. 1). 
Metabolic acidosis resulting from the interdialytic 
accumulation of hydrogen ions generated in the 
course of normal metabolism is common in HD pa-
tients. Correction of metabolic acidosis is one of the 
goals of effective dialysis. Despite the technical ad-
vances in dialysis therapy, pre-dialysis serum HCO3- 
remains lower (values between 19 and 24 mEq/L) 
than normal in most patients receiving HD. In HD 
patients, if respiratory compensation is intact, meta-
bolic acidosis is generally asymptomatic. If necessary 
(pH < 7.15), intravenous sodium bicarbonate thera-
py should be given cautiously in patients with ESRD.
Although hypocalcemia (ionized calcium less 
than 4.2 mg/dL) and hyperphosphatemia (serum 
phosphorus concentration greater than 5 mg/dL) 
is common in dialysis patients, it is usually asymp-
tomatic. Mild hypermagnesemia (2.2–5 mEq/L) 
includes progressive flaccid muscle weakness and 
areflexia. Severe hypermagnesemia (> 5 mEq/L) in-
FIGURE 1. Continuous venovenous hemodiafiltration (CVVHDF) 
in Emergency Department Settings
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tery disease in these patients is 5–30 times greater 
than that of the general population. Putative risk 
factors leading to left ventricular dilation in ESRD 
include volume overload, anaemia, high-flow Ate-
riovenous Fistula (AVF), as well as poorly controlled 
uraemia [10]. The best option to facilitate the with-
drawal of blood for HD is an AVF. It has already 
been shown that the cardiac index (CI) can increase 
12% and 15% respectively 1 and 3 months after 
surgery [11]. High vascular access flow can increase 
CI and can cause high-output cardiac failure [12].
Modern diagnostic tools are needed to assess 
cardiovascular hemodynamic parameters in order 
to offer effective identification and treatment in ED. 
These methods can be divided into the following 
categories: invasive, the so-called “gold standard” 
(pulmonary artery catheter [PAC] — thermodilu-
tion); minimally invasive (pulse contour analysis); 
non-invasive, based on finger pressure measure-
ments with an inflatable finger cuff [13]; imped-
ance cardiography (ICG) [14, 15]; and bioreactance 
technology [16]. Invasive techniques such as PAC 
are risky and restricted to intensive care and oth-
er specialized hospital units [17], while minimally 
invasive methods are suitable for patients with an 
arterial line. Doppler echocardiography and ther-
modilution are not dedicated to serial measure-
ments (beat-to-beat) or trend analyses. Non-inva-
sive methods could be preferable, especially for 
HD patients. Cardiac output (CO) evaluated by ICG 
is closely correlated with measurements utilizing 
thermodilution in patients with or without both 
benign and severe heart failure [18]. The correla-
tion coefficients of PAC and ICG technology range 
from r = 0.63, reported by Cheung et al. [19], to 
r = 0.89, reported by Cotter et al. [20], and de-
pend mainly on the patient study group. There is 
an increasing interest in the better hemodynamic 
management of HD patients, especially in the de-
tection of hemodynamic trends in ED. It is generally 
considered that a standard electrocardiogram has 
a limited ability to predict the risk of CVD during 
dialysis. Haemodialysis-induced hypotension occurs 
in 15% to 30% of HD patients and depends on the 
amount of ultrafiltration and the patient’s compen-
satory response to hypovolemia [21].
The advantage of ICG consists of the possibility 
of continuous measurement of hemodynamic pa-
rameters. With this method, we can immediately 
evaluate (continuous beat-to-beat assessment) the 
condition of the cardiac muscle and the cardiovas-
clude bradycardia, heart blocks, decreased level of 
consciousness, hypotension and cardiac arrest. This 
disorder can be countered with intravenous calcium 
gluconate (5–10 ml of 10% solution) [6]. 
Hypokalemia, hypophosphatemia, and hypo-
magnesemia are uncommon in patients with ESRD. 
Fever in the dialysis patients
Any cause of fever in the general population may 
also occur in the dialysis patient. However, certain 
causes of fever are more common in dialysis pa-
tients and should be given special consideration. 
The most common cause of fever in HD patients is 
access-related infection, especially with central ve-
nous catheters. Infectious complications are a major 
source of morbidity and mortality in HD and PD 
patients. Investigations should include a complete 
blood count and chest X-ray. Febrile HD patients 
with suspected access infection should be hospi-
talized. Opportunistic infections occur frequently in 
such patients. Empiric systemic antibiotics should 
cover Gram-positive and -negative microorganisms, 
while the final regimen should be based on culture 
results. According to US data, the microorganisms 
most frequently isolated during catheter-related 
bacteremia are Staphylococcus aureus and Staph-
ylococcus epidermidis. According to Allon [7], the 
recommended initial antibiotic therapy in HD pa-
tients is Vancomycin 15 mg/kg IV combined with 
gentamicin 1 to 2 mg/kg IV or a third generation 
cephalosporin 1 g IV. The most common cause of 
fever in PD patients is peritonitis. In PD patients, 
any changes to the color or transparency of the di-
alysate fluid is an indication of infection. Other typ-
ically symptoms are tenderness, diffuse abdominal 
pain, nausea or vomiting, diarrhea or constipation, 
while hyperactive or diminished bowel sounds are 
commonly present. Every PD patient with suspect-
ed access infection should be hospitalized. Current 
guidelines recommend intraperitoneal (IP) antibiot-
ics over IV antibiotics. According to Piraino et al. [8], 
the recommended initial antibiotic therapy is Van-
comycin 2 g combined with gentamicin 0.6 mg/kg 
or a third-generation cephalosporin added to 1 bag 
of peritoneal dialysate. 
Cardiovascular emergencies in dialysis patients 
Cardiovascular diseases (CVD) are the leading causes 
of death in the general population (WHO 2012 — ca. 
31%) among patients undergoing HD (ca. 39%) [9] 
and PD (ca. 42%). The relative risk of coronary ar-
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cular system, which makes immediate treatment 
and effective decisions possible. When assessing the 
hemodynamic parameters, the physician has the 
ability to immediately apply fluid therapy or medica-
tion, thus affecting the cardiovascular system. ICG 
is a good method to diagnose and monitor cardiac 
pump function and to explain the mechanisms re-
sponsible for the regulation of blood pressure espe-
cially during hypotension, which remains one of the 
most common complications [22, 23].
Karakitsos et al. [24] performed a prospective 
observational study among 75 HD patients in whom 
measurements were taken on a midweek morning of 
a non-dialysis day. The research showed that the CO 
obtained by ICG (BioZ System) (mean 4.4 ± 1 L) and 
the CO measured by echocardiography (4.3 ± 0.9 L) 
were strongly correlated (r = 0.94; p < 0.001). 
A regression analysis showed that a CO increase 
of 1.0 L/min as measured with echocardiography 
was equivalent to a 0.98 L/min increase as meas-
ured with ICG (95% CI, 0.88–1.08). Among various 
groups of patients, ICG devices were tested in com-
parison with reference devices (intermittent right 
heart thermodilution [ITD]). Most studies include 
patients undergoing cardiac surgery or/and residing 
in intensive care units (ICU). In a meta-analysis by 
Peyton et al. [25], including 13 studies where ICG 
was compared with ITD over 435 measurements, 
the mean bias was –0.10 L/min (± 0.11) (± 95% 
CI), the mean precision was 1.14 L/min while the 
correlation was 0.79. In 24 studies that compared 
the minimally invasive pulse contour method with 
ITD over 714 measurements, the mean bias was 
–0.00 L/min (± 0.09) (± 95% CI), the mean precision 
was 1.22 L/min while the correlation was 0.79. The 
worst results of the ICG method were found among 
ICU patients, a fact which limits the validity and re-
liability of ICG monitoring. Hirschl et al. [26] tested 
Cardioscreen among 29 patients; the mean bias 
was 1.20 while the mean precision was 0.75. En-
goren et al. [27] reported using BioZ; the mean bias 
was 1.00 while the mean precision was 1.30. In 
postoperative cardiac surgery patients (ICU), Gujjar 
et al. [28] reported NICOM mean bias of 0.07 and 
mean precision of 0.68. A study by Wynne [29], us-
ing ICG among 35 HD patients, showed that thorac-
ic fluid content (TFC) decreased in all patients during 
HD sessions (average reduction, 12.7 ± 8 kΏ-1), 
and the correlation of change in TFC with UFV was 
moderate (r = 0.579; p = 0.0003). In the ICG meth-
od, TFC represents an estimation of “preload”.
Dyspnea in dialysis patients 
Careful history-taking is the most useful first step in 
elucidating the aetiology of dyspnea. Fluid overload 
and pulmonary edema is the most frequent cause 
of emergency presentation in dialysis patients [30]. 
The optimal determination of dry weight is a serious 
challenge for clinicians. Besides traditional meth-
ods, such as clinical evaluation and anthropometric 
measurements, more precise ones, such as bioelec-
trical impedance, may be applied in evaluating the 
hydration status of dialysis patients. The dry weight 
definition as proposed by Charra demonstrates the 
key role of hypertension in determining the optimal 
weight, which is determined as a body mass able 
to maintain normal BP without anti-hypertensive 
drugs [31]. In PD patients after ca. 2 years, appears 
hypertonic overhydration due to residual diuresis 
decreases and peritoneal membrane faliure appears 
[32–34]. Contributing factors include preexisting 
left ventricular dysfunction, excessive fluid intake; 
missed dialysis sessions and failure to achieve dry 
weight during dialysis. Patients with fluid overload 
present with the complaints of shortness of breath 
and dyspnea. Physical examination findings include 
hypertension and decreased breath sounds while 
a chest X-ray will show pulmonary vascular conges-
tion and/or pulmonary effusion. In patients with 
respiratory distress, the most useful first step is non-
invasive positive pressure ventilation (NIPPV) using 
CPAP and then, if needed, intubation and ventila-
tory support. Longer intervals also make the patient 
more prone to volume overload. Initial therapy for 
the fluid-overloaded dialysis patient consists of ad-
ministration high-dose intravenous furosemide (in 
patients with residual diuresis) and oxygen supple-
mentation. Usually, emergent HD is the mandatory 
treatment for volume overload and acute pulmonary 
edema [30, 35].
Angina/chest pain in dialysis patients 
In evaluating coronary ischemia in patients with 
ESRD, it is important to understand the limitations 
of the commonly used tests: silent ischemia is more 
common than in the non-dialysis population and 
serum troponin levels may be chronically elevated 
due to reduced eGFR [36]. The dialysis patient with 
acute coronary syndrome should be treated with 
traditional therapies including aspirin, clopidogrel, 
morphine and thrombolytics.
Uremic pericarditis, uremic pleuritis with or with-
out pericardial effusion and deep vein thrombosis 
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should be considered in the differential of chest pain 
in the dialysis patient.
Hypertension in dialysis patients 
Hypertension (HTN) affects 50–90% of HD patients 
and 29–80% of PD patients [37, 38]. A significant 
discrepancy in epidemiological data shows that the 
HTN pathogenesis in RRT patients is multifactorial and 
largely depends on the RRT method and the experi-
ence of the study center. Noncompliance with antihy-
pertensives in this patient population may precipitate 
a hypertensive emergency. Key risks in HD patients in-
clude hypertonic overhydration [17], decreased vascu-
lar compliance [18] and increased renin secretion [35]. 
The initial goal of therapy for hypertensive emergen-
cy is lowering of the mean arterial pressure only by 
20–25% using labetalol and nicardipine. 
Anemia in dialysis patients
Most patients with ESRD will develop a normocytic 
and normochromic anemia. Erythropoietin is iron 
often given to these patients to maintain a hemo-
globin level between 10–11 g/dL. 
EMERGENCIES RELATED TO ACCESS IN 
DIALYSIS PATIENTS
Access to circulation is literally the lifeline of HD 
patients. Blood pressure recording over the AVF and 
the use of the AVF for drawing blood is contrain-
dicated, except as a last resort in situations such 
as cardiopulmonary resuscitation. The absence of 
a palpable thrill or a bruit on auscultation over an 
AVF requires prompt pharmacologic intervention 
in order to dissolve the clot or to perform surgical 
declotting. AVF typically will fail after prolonged use 
due to an aneurysm or thrombosis. 
CONCLUSION
In conclusion, HD and PD patients frequently utilize 
ED services because of their proneness to a va-
riety of emergency medical problems. Impedance 
cardiography is a promising noninvasive tool that 
makes the use of individualized ED care in dialysis 
patients. Dialysis patients should add emergency 
phone numbers for ED and dialysis centers, as they 
will help meet their needs if an emergency happens.
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